XML 103 R83.htm IDEA: XBRL DOCUMENT v3.22.2
INVESTMENTS - Recognition and Measurement of Impairment (Details) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
OTTI on Investments disclosures        
Total impairment losses recognized during the period $ 0 $ 0 $ 0 $ 0
Less: portion of impairment loss recognized in AOCI (before taxes) 0 0 0 0
Net impairment losses recognized in earnings for debt securities that the Company does not intend to sell nor will likely be required to sell 0 0 0 0
Impairment losses recognized in earnings for debt securities that the Company intends to sell, would more-likely-than-not be required to sell or will be subject to an issuer call deemed probable of exercise 90 9 180 78
Total impairment losses recognized in earnings 90 9 180 78
Debt securities available-for-sale (AFS)        
OTTI on Investments disclosures        
Total impairment losses recognized during the period 0 0 0 0
Less: portion of impairment loss recognized in AOCI (before taxes) 0 0 0 0
Net impairment losses recognized in earnings for debt securities that the Company does not intend to sell nor will likely be required to sell 0 0 0 0
Impairment losses recognized in earnings for debt securities that the Company intends to sell, would more-likely-than-not be required to sell or will be subject to an issuer call deemed probable of exercise 90 9 180 78
Total impairment losses recognized in earnings 90 9 180 78
Other assets        
OTTI on Investments disclosures        
Total impairment losses recognized during the period 0 0 0 0
Less: portion of impairment loss recognized in AOCI (before taxes) 0 0 0 0
Net impairment losses recognized in earnings for debt securities that the Company does not intend to sell nor will likely be required to sell 0 0 0 0
Impairment losses recognized in earnings for debt securities that the Company intends to sell, would more-likely-than-not be required to sell or will be subject to an issuer call deemed probable of exercise 0 0 0 0
Total impairment losses recognized in earnings $ 0 $ 0 $ 0 $ 0